Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol

Virology

Volumn 259, Issue 1, 1999, Pages 154-165

  Günthard, Huldrych F ^a   Leigh Brown, Andrew J ^b   D'Aquila, Richard T ^c   Johnson, Victoria A ^d   Kuritzkes, Daniel R ^e   Richman, Douglas D ^a,f   Wong, Joseph K ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; NEVIRAPINE; POL PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; EVOLUTION; GENETIC DISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; MAJOR CLINICAL STUDY; MUTATION; PRIORITY JOURNAL; STRUCTURAL GENE;

EID: 0345363096     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9774     Document Type: Article

References (50)

1. Coffin J. M. Genetic diversity and evolution of retroviruses. Curr. Top. Miocrobiol. Immunol. 176:1992;143-164.
2. Coffin J. M. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science. 167:1995;483-489.
3. Chao L. Fitness of RNA virus decreased by Muller rachet. Nature. 348:1990;454-455.
4. D'Aquila R. T., Hughes M. D., Johnson V. A. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. Ann. Int. Med. 124:1996;1019-1030.
5. De Antoni A., Foli A., Lisziewicz J., Lori F. Mutations in the pol gene of human immunodeficiency virus type 1 in infected patients receiving didanosine and hydroxyurea combination therapy. J. Infect. Dis. 176:1997;899-903.
6. Delassus S., Cheynier R., Wain-Hobson S. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J. Virol. 65:1991;225-231.
7. Delwart E. L., Heng P., Sheppard H. W., Wolpert D., Neumann A. U., Korber B., Mullins J. I. Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J. Virol. 71:1997;7498-7508.
8. Delwart E. L., Pan H., Neumann A., Markowitz M. Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance. J. Virol. 72:1998;2416-2421.
9. De Jong J. J., Jurriaans S., Goudsmit J., Baan E., Huismans R., Danner S., Hillebrand M., ten Veen J. H., de Wolf F. Insertion of two amino acids in reverse transcriptase (RT) during antiretroviral combination therapy: Implications for resistance against nucleoside RT inhibitors. Second International Workshop on HIV Drug Resistance and Treatment Strategies, 24-27 June 1998. Antiviral Ther. 3:1998;15.
10. Diaz R. S., Sabino D. C., Mayer A., Mosley J. W., Busch M. P. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. J. Virol. 69:1995;3273-3281.
11. Duarte E., Clarke D., Moya A., Domingo E. Rapid fitness losses in mammalian RNA virus clones due to Muller Rachet. Proc. Natl. Acad. Sci. USA. 89:1992;6015-6019.
12. Ganeshan S., Dickover R. E., Korber B. T. M., Bryson Y. J., Wolinsky S. M. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J. Virol. 71:1997;663-677.
13. Gu Z., Gao Q., Faust E. A., Wainberg M. A. Possible involvement of cell fusion and viral recombination in generation of human immunodeficiency virus variants that display dual resistance to AZT and 3TC. J. Gen. Virol. 76:1995;2601-2605.
14. Günthard H. F., Wong J. K., Ignacio C. C., Havlir D. V., Richman D. D. Emergence of drug resistance in different tissue compartments in 10 patients using population-based sequencing after 1 year of potent antiretroviral therapy. International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St. Petersburg, FL, 25-28 June 1997 (Intern. Medical Press, London, 1997). Antiviral Ther. 2:1997;67.
15. Günthard H. F., Wong J. K., Ignacio C. C., Guatelli J. C., Riggs N. L., Havlir D. V., Richman D. D. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J. Virol. 72:1998a;2422-2428.
16. Günthard H. F., Wong J. K., Ignacio C. C., Havlir D. V., Richman D. D. Comparative performance of high density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV-1 pol from clinical samples. Aids Res. Human Retroviruses. 14:1998b;869-876.
17. Havlir D. V., Eastman S., Gamst A., Richman D. D. Nevirapine-resistant human immunodeficiency virus: Kinetics of replication and estimated prevalence in untreated patients. J. Virol. 70:1996;7894-7899.
18. Iversen A. K., Shafer R. W., Wehrly K., Winters M. A., Mullins J. I., Chesebro B., Merigan T. C. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J. Virol. 70:1996;1086-1090.
19. Jackson J. B., Kwok S. Y., Sninsky J. J., Hopsicker J. S., Sannerud K. J., Rhame F. S., Henry K., Simpson M., Balfour H. H. Jr. Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J. Clin. Microbiol. 28:1990;16-19.
20. Kellam P., Larder B. A. Retroviral recombination can lead to linkage of reverse transcriptase mutations that conver increased zidovudine resistance. J. Virol. 69:1995;669-674.
21. Korber B. T. M., Allen E. E., Farmer A. D., Myers G. L. Heterogeneity of HIV-1 and HIV-2. AIDS. 9:1995;S5-S18.
22. Kusumi K., Conway B., Cunnigham S., Berson A., Evans C., Iversen A. K. N., Colvin D., Gallo M. V., Coutre S., Shpaer E. G., Faulkner D. V., deRonde A., Volkman S., Williams C., Hirsch M. S., Mullins J. I. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J. Virol. 66:1992;875-885.
23. Leigh Brown A. J., Cleland A. Independent evolution of the env and pol genes of HIV-1 during zidovudine therapy. AIDS. 10:1996;1067-1073.
24. Louwagie J., Janssens W., Mascola J., Heyndrickx L., Hegerich P., van der Groen G., McCutchan F. E., Burke D. S. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69:1995;263-271.
25. McCutchan F. E., Artenstein A. W., Sanders-Buell E., Salminen M. O., Carr J. K., Mascola J. R. Diversity of the envelope glycoprotein among human immundeficiency virus type 1 isolates of clade E from Asia and Africa. J. Virol. 70:1996;3331-3338.
26. Michael N. L., Chang G., Ehrenberg P. K., Vahey M. T., Redfield R. R. HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences. J. Acquired Immune Defic. Syndr. 6:1993;1073-1085.
27. Moutouh, L., Corbeil, J., and Richman, D. D.1996. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc. Natl. Acad. Sci. USA93, 6106-6111.
28. Myers L. E., McQuay L. J., Hollinger F. B. Dilution assay statistics. J. Clin. Microbiol. 32:1994;732-739.
29. Najera I., Holguin A., Quinones-Mateu M. E., Munoz-Fernandez M. A., Najera R., Lopes-Galindez C., Domingo E. Pol gene quasispecies of human immunodeficiency virus: Mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69:1995;23-31.
30. Nowak M. A., Anderson R. R. M., Boerlitffer M. C., May R. M., McMichael A. J. HIV-1 evolution and disease progression. Science. 274:1996;1008-1010.
31. Nowak M. A., Anderson R. M., McLean A. R., Wolfs T. F., Goudsmit J., May R. M. Antigenic diversity thresholds and the development of AIDS. Science. 254:1991;963-969.
32. Richman D. D., Havlir D., Corbeil J., Looney D., Ignacio C., Spector S. A., Sullivan J., Cheeseman S., Barringer K., Pauletti D., Shih C., Myers M., Griffin J. Nevirapine resistance mutations of human immunodeficiency Virus Type 1 selected during therapy. J. Virol. 68:1994;1660-1666.
33. Sabino E. C., Shpaer E. G., Morgado M. G., Korber B. T., Diaz R. S., Bongertz V. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J. Virol. 68:1994;6340-6346.
34. Salminen M. O., Carr J. K., Robertson D. L., Hegerich P., Gotte D., Doch D. Evolution and probable transmission of inter-subtype recombinant HIV-1 in a Zambian couple. J. Virol. 71:1997;2647-2655.
35. Salvatori F., Masiero S., Giaquinto C., Wade C. M., Leigh Brown A. J., Chieco-Bianchi L., De Rossi A. Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. J. Virol. 71:1997;4694-4706.
36. Schinazi R. F., Larder B. A., Mellors J. W. Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance. Int. Antiviral News. 5:1997;129-134.
37. Sheehy N., Desselberger U., Whitwell H., Ball J. K. Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy. J. Gen. Virol. 77:1996;1071-1081.
38. Shirasaka T., Kavlick M. F., Ueno T., Gao W. Y., Kojima E., Alcaide M. L., Chokekijichai S., Roy B. M., Yarchoan R., Mitsuya H. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA. 92:1995;1-5.
39. Simmonds P., Zhang L. Q., McOmish F., Balfe P., Ludlam C. A., Leigh-Brown A. J. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: Implications for models of HIV. J. Virol. 65:1991;6266-6276.
40. Temin, H. M.1993. Retrovirus variation and reverse transcription: Abnormal strand transfers result in retrovirus genetic variation. Proc. Natl. Acad. Sci. USA90, 6900-6903.
41. Wain-Hobson S. The fastest genome evolution ever described: HIV variation in situ. Curr. Opin. Genet. Dev. 3:1993;878-883.
42. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H., Saag M. S., Shaw J. M. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.
43. Whitcomb J. M., Limoli K., Wrin T., Smith D., Tian H., Parkin N., Lie Y. S., Petropoulos C. J. Phenotypic and genotypic analysis of stavudine-resistant isolates. Second International. Workshop on HIV Drug Resistance and Treatment Strategies. 24-27 June 1998. Antiviral Thera. 3:1998;14-15.
44. Winters M. A., Coolley K. L., Girard Y. A., Levee D. J., Hamdan H., Katzenstein D. A., Shafer R. W., Merigan T. C. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. J. Clin. Invest. 102:1998;1769-1775.
45. Wolinsky S. M., Korber B. T. M., Neumann A. U., Daniels M., Kunstman K. J., Whetsell A. J., Furtado M. R., Cao Y., Ho D. D., Safrit J. T., Koup R. A. Adaptive evolution of human immunodeficiency virus-type 1 during the natural Ccurse of infection. Science. 272:1996;537-542.
46. Wong, J. K., Günthard, J. F., Havlir, D. V., Zhang, Z., Haase, A. T., Ignacio, C. C., Kwok, S., Emini, E., and Richman, D. D.1997a. Reduction of HIV-1 in blood and lymph nodes following potent anti-retroviral therapy and the virologic correlates of failure. Proc. Natl. Acad. Sci. USA95, 12574-12579.
47. Wong J. K., Hezareh M., Günthard H. F., Havlir D. V., Ignacio C. C., Spina C. A., Richman D. D. Recovery of replication competent HIV despite prolonged suppression of plasma viremia. Science. 178:1997b;1291-1295.
48. Wong J. K., Ignacio C. C., Torriani F., Havlir D, . Fitch N. J. S., Richman D. D. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues. J. Virol. 71:1997c;2059-2070.
49. Yusa K., Kavlick M. F., Kosalaraksa P., Mitsuya H. HIV-1 acquires resistance to two classes of antiviral drugs through homologous recombination. Antiviral Res. 36:1997;179-189.
50. Zhu T., Wang N., Carr A., Wolinsky S., Ho D. D. Evidence of coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor. J. Virol. 69:1995;1324-1327.